Fredun Pharmaceuticals share news, announcements and annual reports
NSE: FREDUNBSE: 539730Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 2 Nov 2026. Previous close ₹1,367.00.
2 Nov: open ₹1,360.00, high ₹1,420.00, low ₹1,350.10
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹2,380 Cr1,474th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 8.56
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.02%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 18.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.80
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 58,78644.2% delivered
Fredun Pharmaceuticals share news and announcements
665 announcements, routine notices left out, newest first. Page 7 of 14.
Sep 2022
23 Sep · Compliance Of Regulation 44 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations').
Aug 2022
27 Aug · Board meeting
24 Aug · Board meeting
Meeting on 27 Aug 2022: preferential issue of shares24 Aug · Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015
5 Aug · Board meeting
Meeting on 12 Aug 2022: quarterly results1 Aug · Board meeting
Meeting on 1 Aug 2022
Jul 2022
Jun 2022
10 Jun · Announcement under Regulation 30 (LODR)-Allotment
May 2022
27 May · Non-Applicability Of Regulation 23 (9) Of SEBI (LODR) Regulations, 2015 Regarding Submission Of Disclosures Of Related Party Transactions For The Year Ended 31St March. 2022
9 May · Board meeting
Meeting on 16 May 2022: final dividend and audited results
Apr 2022
23 Apr · Legal
Exchange has sought clarification from Fredun Pharmaceuticals Ltd on April 22, 2022 with reference to significant movement in price, in order to ensure that investors have latest relevant ....20 Apr · Yearly Certificate Under Regulations 40(9) Of SEBI Listing Regulations, 2015
9 Apr · Yearly Compliance Certificate Under Regulation 7(3) Of Sebl Listing Regulations, 2015
8 Apr · Board meeting
Meeting on 8 Apr 20228 Apr · Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Mar 2022
14 Mar · Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Feb 2022
21 Feb · Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Jan 2022
19 Jan · Board meeting
Meeting on 28 Jan 2022: quarterly results11 Jan · Shareholding for the Period Ended December 31, 2021
Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click ....7 Jan · Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Dec 2021